N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01491243
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01491243
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01491243. Randomized; single masking; primary purpose diagnostic. Start 2014-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy
- Acronym
- NEW-MOON
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Intensive treatment with sodium bicarbonate
- Intervention (Drug)
- Standard treatment with saline infusion
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01491243- Content hash
eb105b35ea685d70ccbf662f3dd968c8f77f7f24c62deaffa19e6304e14ab9ea